ArticleBMC chemistry2026
From design space to green space: an analytical quality by design-assisted high-performance liquid chromatography method for the quantification of triple-combination antihypertensive drugs.
Article in BMC chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Micellar Enhanced Second Derivative Spectrofluorimetric Determination of Hydrochlorothiazide, Amlodipine, and Telmisartan in Fixed Dose Combination and Spiked Human Plasma.Luminescence : the journal of biological and chemical luminescence · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To develop a reliable, High-performance Liquid Chromatography technique for the simultaneous determination of a Fixed-Dose Combination of hydrochlorothiazide, amlodipine besylate, and telmisartan. The concepts of Green Analytical Chemistry and Analytical Quality by Design are combined in this work. For optimal results, Shim-pack C18 (4.6 × 250 mm, 5 µm particle size) was utilized. With an injection volume of 20 µL, a gradient of isopropanol: acetate buffer (0.1 M, pH 5.8) as a buffer, at a flow rate of 1.075 mL/min, and UV detection at 324 nm, the mobile phase was composed. The retention times for hydrochlorothiazide (HCT), amlodipine besylate (AML), and telmisartan (TEL) were found to be 3.192, 4.515, and 5.097 min, respectively. All parameters, including relative standard deviation, accuracy, precision, linearity, robustness, and specificity, were examined and found to be less than 2% for the proposed approach. Dong's algorithm computations have identified and verified the areas where the method's optimization is carried out in the design space allotted to the developed method for estimating these drugs in combination dose forms. The developed method was validated and found to be successful in identifying the three drugs in commercially available tablets. In addition to this the method sustainability was assessed with a comprehensive multi-parameter evaluation adopting various sustainability assessment tools including carbon footprint estimation and mobile phase greenness assessment using the Green Environmental Assessment and Rating for Solvents (GEARS), and environmental impact indices such as the Red Analytical Performance Index (RAPI), Click Analytical Chemistry Index (CACI), Blue Applicability Grade Index (BAGI), Modified Green Analytical Procedure Index (MoGAPI), Analytical GREEnness prep (AGREEprep), Analytical Green Star Area (AGSA), and RGBfast. The collective outcomes of these assessments demonstrated that the proposed method is environmentally benign, as it employs fewer hazardous chemicals, generates reduced waste, and requires lower energy consumption.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.